MedTrace Logo

ApneaLink Air Home Sleep Testing (HST) Device Validation Study

NCT03470493 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2021-05-20

Study results available
· View outcomes & findings →

Summary

This study compares the diagnostic capability of a home sleep apnea testing device to polysomnography.

Conditions

  • Sleep-disordered Breathing

Interventions

DIAGNOSTIC_TEST

ApneaLink Air

ApneaLink Air to be used on each participant undergoing PSG

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Richard Berry, MD · University of Florida

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-11
Primary Completion
2019-03-06
Completion
2019-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03470493 on ClinicalTrials.gov